ORG-26576

ORG-26576
Identifiers
	IUPAC name (9aS)-8,9,9a,10-Tetrahydro-5H,7H-pyrido[3,2-f]pyrrolo[2,1-c][1,4]oxazepin-5-one;
CAS Number	1026791-61-6;
PubChem CID	13584912;
ChemSpider	32697513;
UNII	0H1IDR8Z4F;
CompTox Dashboard (EPA)	DTXSID001336129 ;
Chemical and physical data
Formula	C11H12N2O2
Molar mass	204.229 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1C[C@H]2COC3=C(C=CC=N3)C(=O)N2C1;
	InChI InChI=1S/C11H12N2O2/c14-11-9-4-1-5-12-10(9)15-7-8-3-2-6-13(8)11/h1,4-5,8H,2-3,6-7H2/t8-/m0/s1; Key:FIKUEZUFASUKAH-QMMMGPOBSA-N;

ORG-26576 is an ampakine originally developed by Cortex Pharmaceuticals and then licensed to Organon International for development. In animal studies it has been shown to effectively potentiate AMPA receptor function, leading to increased BDNF release and enhanced neuronal differentiation and survival, as well as producing nootropic effects in standardised assays.^[1]^[2]^[3]^[4]^[5]^[6] Development as an antidepressant has been halted due to a failed Phase II trial for major depressive disorder.^[7]

Quick Facts Identifiers, CAS Number ...

[1]

[2]

[3]

[4]

[5]

[6]

[7]

ORG-26576

See also

References

Wikiwand - on